China approaches record 500m shots administered, likely to ‘produce 3b by year-end’
Hu Yuwei and Yu Xi Published: May 23, 2021 09:22 PM
A medical worker administers a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot to a resident at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021.Photo:Xinhua
China is expected to produce more than 3 billion doses by the end of this year and become the first in the world to have administered 500 million shots of COVID-19 vaccines, despite temporary shortages in some places due to booming willingness to take the shots amid the latest domestic cases.
Beijing very close to become first Chinese city with herd immunity: experts
thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
file7fokwivj0q9byjr4gak
BEIJING, May 11. Global Times: The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand.
After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year.
Source：
2021-05-11 18:03
The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand.
After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year.
China fills vaccine gap left by US, India with expanded production to reach 5b doses annually
Global Times reporter on society, cybersecurity, diplomatic relations and topics related to Xinjiang.
Liu Caiyu and Leng Shumei Published: May 10, 2021 10:13 PM Updated: May 11, 2021 10:18 AM
A nurse shows a vial of the Sinopharm vaccine at the Panadura Health Office in Kalutara District, in the outskirts of capital Colombo, Sri Lanka, on May 8, 2021. Sri Lanka s Health Ministry on Saturday began administering the Sinopharm vaccine to local nationals, soon after the World Health Organization (WHO) approved it for emergency use worldwide.(Photo: Xinhua)
The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global
vimarsana © 2020. All Rights Reserved.